Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ACRV
#3450
Acrivon Therapeutics, Inc. Common Stock
1.5
1
-17.03%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-17.03%
Variazione Mensile
-23.74%
Variazione di 6 mesi
+11.03%
Variazione Annuale
-71.51%
Chiusura Precedente
1.8
2
Open
1.5
1
Bid
Ask
Low
1.5
1
High
1.5
1
Volume
10
Mercati
Mercato Azionario Statunitense
Salute
ACRV
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
31.14 M
31.35 M
31.36 M
31.46 M
31.56 M
—
Valuation ratios
Enterprise value
174.54 M
148.92 M
24.5 M
-4.46 M
21.71 M
190.66 M
Price to earnings ratio
-2.58
-2.53
-0.94
-0.54
-0.87
-4.89
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
3.25
3.1
1.09
0.62
1.02
5.83
Price to book ratio
0.33
1.15
0.1
0.07
0.11
1.42
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.12
0.11
0.13
0.13
0.49
Return on equity %
0.11
0.13
0.12
0.15
0.14
0.54
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
12.75
10.55
11.17
10.31
8.75
40.78
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.45
0.51
0.51
0.43
0.32
1.77
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
4.92
5.31
3.9
3.57
3.35
16.14
Net current asset value per share
4.96
5.37
3.95
3.6
3.38
16.3
Tangible book value per share
5.17
5.23
4.18
3.72
3.34
16.47
Working capital per share
4.57
4.87
3.59
3.25
2.99
14.7
Book value per share
5.17
5.23
4.18
3.72
3.34
16.47
Notizie
Acrivon presenterà i dati sul cancro endometriale di ACR-368 al congresso ESGO
Acrivon to present ACR-368 endometrial cancer data at ESGO congress
Sunday’s Insider Activity: Top Executives Make Strategic Moves
Il CEO di Acrivon Therapeutics Blume-Jensen acquista azioni per 82.000 dollari
Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares
Il COO di Acrivon Therapeutics Devroe acquista azioni per 17mila dollari
Acrivon Therapeutics COO Devroe buys $17k in shares
Piper Sandler alza il target di prezzo di Acrivon Therapeutics a $8 su dati positivi sul cancro
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data
Il crollo del titolo Acrivon Therapeutics dopo risultati contrastanti nei trial sul cancro
Acrivon Therapeutics stock plunges after mixed cancer trial results
Why Is Acrivon Therapeutics Stock Falling Today? - Acrivon Therapeutics (NASDAQ:ACRV)